Stelara for Plaque psoriasis
Quick answer: Stelara is used for Plaque psoriasis as part of a il-12/il-23 inhibitor (monoclonal antibody) treatment regimen. Ustekinumab is a human monoclonal antibody binding the p40 subunit of IL-12 and IL-23, blocking Th1/Th17 inflammatory pathways The specific dosing for Plaque psoriasis is determined by your prescriber based on individual factors.
Why is Stelara used for Plaque psoriasis?
Stelara belongs to the IL-12/IL-23 inhibitor (monoclonal antibody) class. Ustekinumab is a human monoclonal antibody binding the p40 subunit of IL-12 and IL-23, blocking Th1/Th17 inflammatory pathways This action makes it useful for treating or managing Plaque psoriasis in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Stelara is the right choice for a specific patient depends on the type and severity of Plaque psoriasis, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Plaque psoriasis
Common adult dosing range: 45-90 mg SC every 12 weeks (after induction). The actual dose for Plaque psoriasis depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Stelara medicine page.
What to expect
Stelara treatment for Plaque psoriasis typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Plaque psoriasis
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Stelara is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all IL-12/IL-23 inhibitor (monoclonal antibody) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Stelara
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Stelara full prescribing information · All IL-12/IL-23 inhibitor (monoclonal antibody) alternatives
Frequently asked questions
How effective is Stelara for Plaque psoriasis?
Effectiveness varies by individual response, dose, and severity. Stelara is one of several treatment options for Plaque psoriasis, supported by clinical evidence within the il-12/il-23 inhibitor (monoclonal antibody) class. Discuss expected response with your prescriber.
How long do I need to take Stelara for Plaque psoriasis?
Treatment duration depends on the nature of Plaque psoriasis — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Stelara when used for Plaque psoriasis?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Stelara for Plaque psoriasis?
Yes. Multiple medicines and non-drug options exist for Plaque psoriasis. Alternatives within the il-12/il-23 inhibitor (monoclonal antibody) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.